Clinical Trial Update: Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for palifermin in patients receiving hematopoietic stem cell transplantation to prevent mucositis; the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucositis

Drugs mentioned

• Kepivance (Palifermin)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Mucositis | Phase 3 | Status: UNKNOWN